BIBLIOGRAPHIC RECORD

A phase 2 uncontrolled, open-label study of intranasal BPL-003 (5-methoxy-<i>N,N</i>-dimethyltryptamine) in patients with treatment-resistant depression.

This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.

Recorded authors
Claire Roberts; Mathieu Seynaeve; Anna O Ermakova; Fiona Dunbar; Hattie Wells; Adeep Puri; Catherine Bird; James J Rucker
Source of metadata
PubMed
Year recorded
2026

Public identifiers and source

Open the source record

Reference

Claire Roberts; Mathieu Seynaeve; Anna O Ermakova; Fiona Dunbar; Hattie Wells; Adeep Puri; Catherine Bird; James J Rucker. (2026). A phase 2 uncontrolled, open-label study of intranasal BPL-003 (5-methoxy-<i>N,N</i>-dimethyltryptamine) in patients with treatment-resistant depression. https://pubmed.ncbi.nlm.nih.gov/41761045/

Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.